Prot #ALT-002-SRE-01: A Phase I/II Dose Escalation Study of AP-002 In Patients with Advanced or Recurrent Solid Tumors

Project: Research project

Project Details

StatusActive
Effective start/end date12/9/1912/9/22

Funding

  • Altum Pharmaceuticals Inc. (Prot #ALT-002-SRE-01)